Laurion Capital Management LP Uro Gen Pharma Ltd. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.72 - $19.2 $1.14 Million - $1.73 Million	-90,000 Reduced 35.91%	160,600 $2.69 Million
Q4 2023 Feb 14, 2024	SELL	$10.87 - $15.93 $1.29 Million - $1.89 Million	-118,505 Reduced 32.11%	250,600 $3.76 Million
Q2 2023 Aug 14, 2023	SELL	$8.75 - $14.29 $100,581 - $164,263	-11,495 Reduced 3.02%	369,105 $3.82 Million
Q2 2022 Aug 15, 2022	BUY	$5.12 - $8.74 $1.95 Million - $3.33 Million	380,600 New	380,600 $3.12 Million
Q1 2018 May 14, 2018	SELL	$38.64 - $57.54 $1.83 Million - $2.73 Million	-47,473 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$27.28 - $43.26 $1.3 Million - $2.05 Million	47,473	47,473 $1.77 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.